4-己基-4-[2-(4-异硫氰基苯基)乙基]-1,1-联苯基 | 110499-97-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 中文名称: 4-己基-4-[2-(4-异硫氰基苯基)乙基]-1,1-联苯基
• 英文名称: 4-Hexyl-4'-[2-(4-isothiocyanatophenyl)ethyl]-1,1'-biphenyl
• 英文别名: 1-hexyl-4-[4-[2-(4-isothiocyanatophenyl)ethyl]phenyl]benzene
• CAS: 110499-97-3
• 化学式: C₂₇H₂₉NS
• 分子量: 399.6
• InChiKey: KXHHFPNEPTUIEF-UHFFFAOYSA-N

物化性质

• 稳定性/保质期：

  如果按照规格使用和储存，不会发生分解，并且没有已知的危险反应。应避免与强氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  10.1
• 重原子数：
  29
• 可旋转键数：
  10
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  44.4
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• WATER-SOLUBLE POLYSACCHARIDE ETHERS AND THEIR USE
  申请人：Ritter Helmut

  公开号：US20120238524A1

  公开（公告）日：2012-09-20

  The invention relates to modified polysaccharide ethers having a weight-averaged molecular weight of 40000 to 50000 g/mole, zero shear viscosity of more than 10 Pas, and pseudoplasticity of more than 20, obtainable by reacting cellulose-based polysaccharide ether(s) with at least one mesogenic modification agent or modified polysaccharide ethers, obtainable by reacting polysaccharide ether(s) selected from the group consisting of hydroxypropylmethyl cellulose (HPMC), hydroxyethylmethyl cellulose (HEMC), methyl cellulose, and cellulose ethers with methyl and/or ethyl and/or propyl groups and mixtures thereof, with at least one mesogenic modification agent. Said substances can be used to produce gel-like to stable aqueous preparations having viscoelastic flow properties, which are suited for use in the human body, particularly within the scope of ophthalmologic procedures.

  本发明涉及一种具有重量平均分子量为40000至50000克/摩尔，零剪切粘度大于10帕斯，伪塑性大于20的改性多糖醚，其可通过将基于纤维素的多糖醚与至少一种介向改性剂或改性多糖醚反应获得，或通过将选自羟丙基甲基纤维素（HPMC）、羟乙基甲基纤维素（HEMC）、甲基纤维素和甲基和/或乙基和/或丙基基团和其混合物的纤维素醚与至少一种介向改性剂反应获得。这些物质可用于制备凝胶状到稳定的水性制剂，具有黏弹性流动特性，适用于人体内使用，特别是在眼科手术范围内。
• Liquidcrystalline cyclohexylbenzene derivatives their manufacturing and novel nematic admixtures containing same
  申请人：Wojskowa Akademia Techniczna im. Jaroslawa Dabrowskiego

  公开号：EP0272580B1

  公开（公告）日：1994-08-17
• WASSERLÖSLICHE POLYSACCHARIDETHER UND IHRE VERWENDUNG
  申请人：PHARMPUR GmbH

  公开号：EP2467425B1

  公开（公告）日：2020-10-07
• LIQUID CRYSTAL COMPOSITION
  申请人：INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY

  公开号：US20150137036A1

  公开（公告）日：2015-05-21

  Provided is a liquid crystal composition. The liquid crystal composition includes 1 to 50 wt % of an achiral smectic liquid crystal, and a remaining amount of a nematic liquid crystal. The nematic liquid crystal includes a negative nematic liquid crystal.
• LIQUID CRYSTAL DISPLAY DEVICE
  申请人：INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY

  公开号：US20150370135A1

  公开（公告）日：2015-12-24

  Provided are a liquid crystal display device and a method for driving same. The liquid crystal display device comprises the liquid crystal display device in a PVA mode, an LVA mode, an FFS mode, and in an IPS mode. The liquid crystal display device comprises 1 to 50 wt % of an achiral smectic liquid crystal, and a remainder of a nematic liquid crystal. The liquid crystal device comprises 3 to 50 wt % of a smectic liquid crystal and a remainder of the nematic liquid crystal, wherein the smectic liquid crystal comprises a liquid crystal layer, comprising 70 to 97 wt % of an achiral smectic liquid crystal, and 3 to 30 et % of a chiral smectic liquid crystal.